ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.848,77
-0,34%
S&P 500
5.956,00
0,42%
Dow Jones
42.791,63
-0,11%
Euro vs US Dollar
1,0399
-0,32%
Bitcoin
93.426,96
-1,77%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Avantor Inc (AVTR)

  7. Avantor Inc (AVTR) News

AVTR

Avantor (AVTR)

Avantor Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:AVTR
DatumZeitQuelleÜberschriftSymbolFirma
20/11/202414h05PR Newswire (US)Avantor® to Participate in the 7th Annual Evercore ISI HealthCONx ConferenceNYSE:AVTRAvantor Inc
14/11/202419h28Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:AVTRAvantor Inc
14/11/202414h05PR Newswire (US)Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest ChallengesNYSE:AVTRAvantor Inc
06/11/202423h29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AVTRAvantor Inc
06/11/202423h26Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:AVTRAvantor Inc
06/11/202414h29Edgar (US Regulatory)Form 8-K - Current reportNYSE:AVTRAvantor Inc
06/11/202414h05PR Newswire (US)Avantor® Appoints Dame Louise Makin, DBE, Ph.D., to its Board of DirectorsNYSE:AVTRAvantor Inc
25/10/202415h04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:AVTRAvantor Inc
25/10/202412h19Edgar (US Regulatory)Form 8-K - Current reportNYSE:AVTRAvantor Inc
25/10/202412h07IH Market NewsUS Futures Rise; Oil Prices Edge HigherNYSE:AVTRAvantor Inc
25/10/202412h05PR Newswire (US)Avantor® Reports Third Quarter 2024 ResultsNYSE:AVTRAvantor Inc
23/10/202414h05PR Newswire (US)Avantor® Strengthens Partnership with National Institute for Bioprocessing Research and Training (NIBRT) to Address Critical Biopharma Industry ChallengesNYSE:AVTRAvantor Inc
18/10/202413h05PR Newswire (US)Avantor® Closes Previously Announced Divestiture of its Clinical Services BusinessNYSE:AVTRAvantor Inc
04/10/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AVTRAvantor Inc
30/09/202414h05PR Newswire (US)Avantor® Wins Kaizen Institute Award for Excellence in Process Improvement and Quality ManagementNYSE:AVTRAvantor Inc
27/09/202414h05PR Newswire (US)Avantor® to Host Third Quarter 2024 Earnings Call on Friday, October 25, 2024NYSE:AVTRAvantor Inc
25/09/202415h05PR Newswire (US)Avantor® Joins Pharmaceutical Industry-Sponsored Energize Virtual Power Purchase AgreementNYSE:AVTRAvantor Inc
23/09/202414h05PR Newswire (US)Avantor® Participates in BioProcess International 2024 Conference Scientific Program and ExhibitionNYSE:AVTRAvantor Inc
12/09/202414h05PR Newswire (US)Avantor® Achieves Bronze Medal from EcoVadis for Sustainability PerformanceNYSE:AVTRAvantor Inc
06/09/202422h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AVTRAvantor Inc
05/09/202420h59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AVTRAvantor Inc
26/08/202421h59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AVTRAvantor Inc
22/08/202414h05PR Newswire (US)Avantor® to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceNYSE:AVTRAvantor Inc
16/08/202422h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AVTRAvantor Inc
16/08/202413h35PR Newswire (US)Avantor® Enters into Definitive Agreement to Divest Clinical Services Business to Audax Private EquityNYSE:AVTRAvantor Inc
08/08/202414h05PR Newswire (US)Wheels Up Announces Gregory Summe to Join Board of DirectorsNYSE:AVTRAvantor Inc
01/08/202422h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AVTRAvantor Inc
26/07/202423h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AVTRAvantor Inc
26/07/202422h03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AVTRAvantor Inc
26/07/202415h02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:AVTRAvantor Inc
 Showing the most relevant articles for your search:NYSE:AVTR

Kürzlich von Ihnen besucht

NYSE
JPM
JP Morgan Chase
TG
DTE
Deutsche Telekom
TG
MBG
MercedesBenz
DBI
TDXP
Tec DAX
NYSE
DIS
Walt Disney
TG
TUI1
Tui
AMEX
XLF
Financial Select Sector
USOTC
BNPQY
BNP Paribas (QX)
PM
XAUUSD
Gold vs US Dollar
COIN
XRPUSD
Ripple
NASDAQ
NVDA
NVIDIA
COIN
ETHUSD
Ethereum
TG
D7G
Nel ASA
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten